Why We Built Thalocan: The Forgotten Links in Dermatology Clinical Trials Interview with Eric Zudak, CEO of Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. There’s a moment in every startup story when frustration turns into fuel. For Eric Zudak, founder of Thalocan Research Innovations, that moment came when a global pharmaceutical company called…
Teresa DeHaemer, our Senior Director of Business Strategy shares just a small part of her experience at hashtag#RAD2025 – The Revolutionizing Atopic Dermatitis conference in Nashville, which took place June 6th and 7th. Joined by Tyler White, our Senior Director of Business Development, Thalocan Research Innovations expresses our sincere thanks for all the insight, presentations,…
In recognition of Hidradenitis Suppurativa Awareness week, Thalocan Research Innovations is proud to present our full conversation with Portia Combow, who graciously shares her story about living with HS for nearly twenty years. The generosity of people like Portia not only recognizes all of those who cope with this disease, but serves to inform many…
The third installment in our series, Conversations with Portia Combow: After being incorrectly diagnosed, first with a staph infection and then with folliculitis – Portia discusses her experience and the treatment options she pursued prior to getting correctly diagnosed with Hidradenitis Suppurativa. Watch the full webinar/conversation at www.thalocan.com/webinars/.
